Compare Across Protocol (ACX) vs Mira (MIRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Across Protocol vs Mira — how do they compare? Across Protocol trades at Rp742.59 (market cap Rp505,3M, Rp188,8M 24h volume), while Mira trades at Rp698.2 (market cap Rp224,51M, Rp102,44M 24h volume). The key difference: Across Protocol is far larger — about 2.3× Mira's market cap, and Across Protocol 's circulating supply is 716,5M / 1B ACX (72%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Across Protocol for 57 Days and Mira for 22 Days on average.
| ACX | MIRA | |
|---|---|---|
Market Cap | Rp505,3M | Rp224,51M |
Volume (24h) | Rp188,8M | Rp102,44M |
Circulating Supply | 716,5M / 1B ACX (72%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 57 Days | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Across Protocol (ACX) is trading at Rp728.43 with a market cap of Rp505.3M, showing bearish technical signals with 15 sell signals versus 3 buys. The token is near its pivot point of Rp714, with key support at Rp665 and resistance at Rp751. With 72% of max supply in circulation and average hold time of 57 days, the token shows moderate distribution. No major protocol updates or ecosystem developments have been reported recently.
Overall outlook remains cautious with bearish technical dominance. Key opportunity lies in oversold RSI conditions suggesting potential bounce, while major risks include low liquidity and concentrated sell pressure. Investors should monitor support levels closely and watch for any protocol developments that could shift momentum.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Across Protocol
Across (ACX) is a cross-chain token bridge secured by UMA's optimistic oracle. Designed for capital efficiency, ACX features a single liquidity pool, competitive relayer options, and a no-slippage fee model. Because its oracle verifies transfers optimistically, ACX is able to process cross-chain transfers quickly.
Read more on ACX →About Mira
Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →
